Literature DB >> 35755559

Early-Age Manifestation of Singleton Merten Syndrome With Systemic Lupus Erythematosus Features: A Case Report.

Yazeed M Alzahrani1, Ahmad A Alamoudi1, Nojoud K Nahar1, Rawia F Albar2.   

Abstract

Singleton Merten syndrome (SMS) is one of the rarest multisystem genetic disorders that had been recognized in only a few cases. Patients who have this syndrome often present with calcification of the aorta and heart valves, dental dysplasia, joint calcification, distinct facial features, and growth and developmental delay. Other physical findings usually associated with SMS may include glaucoma, skeletal abnormalities including tendon rupture, muscle weakness, and arthropathy. In individuals with SMS, autoimmune diseases like psoriasis and systemic lupus erythematosus (SLE) can occur. In this case, we report a pre-term baby girl that developed congenital aortic calcification, renal hypertension, dental anomalies, multiple joint calcifications, atypical facial features, mild mental retardation, and developmental delay. At 17 years, the patient developed SLE based on positive antinuclear antibody (ANA) with clinical and immunological features like fever, malar rash, pericardial effusion, proteinuria, high ANA concentration, high anti-double-stranded DNA, low C4 complement, and presence of anti-Smith antibodies.
Copyright © 2022, Alzahrani et al.

Entities:  

Keywords:  congenital aortic calcification; joints calcification; persistent hypertension; singleton merten syndrome; systematic lupus erythematoses

Year:  2022        PMID: 35755559      PMCID: PMC9217668          DOI: 10.7759/cureus.25244

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  15 in total

1.  Singleton-Merten syndrome: an autosomal dominant disorder with variable expression.

Authors:  Annette Feigenbaum; Christine Müller; Christopher Yale; Johannes Kleinheinz; Peter Jezewski; Hans Gerd Kehl; Mary MacDougall; Frank Rutsch; Raoul C M Hennekam
Journal:  Am J Med Genet A       Date:  2013-01-15       Impact factor: 2.802

2.  Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children.

Authors:  Marie-Louise Frémond; Mathieu Paul Rodero; Nadia Jeremiah; Alexandre Belot; Eric Jeziorski; Darragh Duffy; Didier Bessis; Guilhem Cros; Gillian I Rice; Bruno Charbit; Anne Hulin; Nihel Khoudour; Consuelo Modesto Caballero; Christine Bodemer; Monique Fabre; Laureline Berteloot; Muriel Le Bourgeois; Philippe Reix; Thierry Walzer; Despina Moshous; Stéphane Blanche; Alain Fischer; Brigitte Bader-Meunier; Fréderic Rieux-Laucat; Yanick Joseph Crow; Bénédicte Neven
Journal:  J Allergy Clin Immunol       Date:  2016-08-20       Impact factor: 10.793

3.  Brief Report: IFIH1 Mutation Causes Systemic Lupus Erythematosus With Selective IgA Deficiency.

Authors:  Lien Van Eyck; Lien De Somer; Diana Pombal; Simon Bornschein; Glynis Frans; Stéphanie Humblet-Baron; Leen Moens; Francis de Zegher; Xavier Bossuyt; Carine Wouters; Adrian Liston
Journal:  Arthritis Rheumatol       Date:  2015-06       Impact factor: 10.995

4.  Progressive supra-aortic stenosis in a young adult with the findings of Singleton Merten Syndrome.

Authors:  Arda Ozyuksel; Cihangir Ersoy; Emir Canturk; Atif Akcevin
Journal:  BMJ Case Rep       Date:  2014-09-05

5.  An open-label trial of JAK 1/2 blockade in progressive IFIH1-associated neuroinflammation.

Authors:  Kavitha Kothur; Sushil Bandodkar; Stephanie Chu; Louise Wienholt; Alexandra Johnson; Peter Barclay; Paul A Brogan; Gillian I Rice; Yanick J Crow; Russell C Dale
Journal:  Neurology       Date:  2018-01-10       Impact factor: 9.910

6.  Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling.

Authors:  Gillian I Rice; Yoandris Del Toro Duany; Emma M Jenkinson; Gabriella Ma Forte; Beverley H Anderson; Giada Ariaudo; Brigitte Bader-Meunier; Eileen M Baildam; Roberta Battini; Michael W Beresford; Manuela Casarano; Mondher Chouchane; Rolando Cimaz; Abigail E Collins; Nuno Jv Cordeiro; Russell C Dale; Joyce E Davidson; Liesbeth De Waele; Isabelle Desguerre; Laurence Faivre; Elisa Fazzi; Bertrand Isidor; Lieven Lagae; Andrew R Latchman; Pierre Lebon; Chumei Li; John H Livingston; Charles M Lourenço; Maria Margherita Mancardi; Alice Masurel-Paulet; Iain B McInnes; Manoj P Menezes; Cyril Mignot; James O'Sullivan; Simona Orcesi; Paolo P Picco; Enrica Riva; Robert A Robinson; Diana Rodriguez; Elisabetta Salvatici; Christiaan Scott; Marta Szybowska; John L Tolmie; Adeline Vanderver; Catherine Vanhulle; Jose Pedro Vieira; Kate Webb; Robyn N Whitney; Simon G Williams; Lynne A Wolfe; Sameer M Zuberi; Sun Hur; Yanick J Crow
Journal:  Nat Genet       Date:  2014-03-30       Impact factor: 38.330

7.  Singleton Merten Syndrome: A Rare Cause of Early Onset Aortic Stenosis.

Authors:  Harshavardhan Ghadiam; Sudhir Mungee
Journal:  Case Rep Cardiol       Date:  2017-02-21

8.  DDX58 and Classic Singleton-Merten Syndrome.

Authors:  Carlos R Ferreira; Yanick J Crow; William A Gahl; Pamela J Gardner; Raphaela Goldbach-Mansky; Sun Hur; Adriana Almeida de Jesús; Michele Nehrebecky; Ji Woo Park; Tracy A Briggs
Journal:  J Clin Immunol       Date:  2018-12-20       Impact factor: 8.317

9.  Singleton-Merten syndrome: A rare cause of femoral head necrosis.

Authors:  Elio Assaf; Mohamad Bdeir; Elisabeth Mohs; Franz-Joseph Dally; Sascha Gravius; Cleo-Aron Weis; Ali Darwich
Journal:  Am J Med Genet A       Date:  2021-06-30       Impact factor: 2.802

10.  Unusual cutaneous features associated with a heterozygous gain-of-function mutation in IFIH1: overlap between Aicardi-Goutières and Singleton-Merten syndromes.

Authors:  A-C Bursztejn; T A Briggs; Y del Toro Duany; B H Anderson; J O'Sullivan; S G Williams; C Bodemer; S Fraitag; F Gebhard; B Leheup; I Lemelle; A Oojageer; E Raffo; E Schmitt; G I Rice; S Hur; Y J Crow
Journal:  Br J Dermatol       Date:  2015-10-29       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.